Skip to main content

Table 1 Patient Demographics

From: Cholinergic Anti-Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis

 

RA

Controls

P value

M/F (n)

4/9

5/6

ns

Age (years)

52 (32–82)

38 (26–73)

0.05

Disease Duration (years)

13

-

-

Rheumatoid-factor positive (%)

11(85%)

-

-

C-reactive protein (mg/L)

14.5 (0.2–5.9)

1 (0.4–2.9)

P<0.01

Disease activity score-28 (mean ± SD)

4.5 ± 0.94

co-Morbidities:

   

HTN

0

1

ns

Hypothyroidism

1

1

ns

SLE

1

0

ns

Medications:

   

Corticosteroids

7

0

0.006

NSAIDS

2

0

ns

β-Blockers

2

0

ns

Calcium Channel Antagonists

0

1

ns

DMARDs

10

0

0.002

TNF receptor Blockers

7

0

0.005

  1. aData expressed as median values. Range is given in parentheses. DAS-28 score is expressed as mean ± SD.